[
  {
    "info": {
      "NCT": "NCT04901806",
      "Protocol_No": "PBI-200-101",
      "jit": "Caris",
      "trial_name": "Pyramid Biosciences PBI-200-101"
    },
    "disease": {
      "summary": "Solid Tumor, Adult | Brain Tumor, Primary | Desmoplastic Small Round Cell Tumor",
      "details": [
        {
          "code": "CNS/Brain (BRAIN)",
          "selection": "include",
          "stage": "Advanced Stage ;Metastatic"
        },
        {
          "code": "Desmoplastic Small-Round-Cell Tumor (DSRCT)",
          "selection": "include",
          "stage": "Advanced Stage ;Metastatic"
        },
        {
          "code": "Solid Tumors",
          "selection": "include",
          "stage": "Advanced Stage ;Metastatic"
        }
      ]
    },
    "query": {
      "nct": "NCT04901806",
      "title": "Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors",
      "current_status": "Recruiting",
      "status_verif_date": "September 2022",
      "last_update_date": "September 13, 2022",
      "trial_hold_status": "open",
      "sponsor": "Pyramid Biosciences",
      "brief_summary": "This is a first-in-human, Phase 1/2 open-label, multicenter, dose-escalation, safety, PK, and biomarker study of PBI-200 in subjects with NTRK-fusion-positive advanced or metastatic solid tumors.",
      "conditions": "Solid Tumor, Adult | Brain Tumor, Primary | Desmoplastic Small Round Cell Tumor",
      "type": "Interventional",
      "phase": "Phase 1 | Phase 2",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "Phase 1 Dose Escalation",
          "drug": "PBI-200",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Phase 1 Dose Escalation",
              "Gene": "NTRK",
              "Gene2": "Not available",
              "Type": "Fusion",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "positive",
              "summary": "NTRK Fusion positive  "
            },
            {
              "cohort": "Phase 1 Dose Escalation",
              "Gene": "NTRK",
              "Gene2": "Not available",
              "Type": "Amplification",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "positive",
              "summary": "NTRK Amplification positive  "
            },
            {
              "cohort": "Phase 1 Dose Escalation",
              "Gene": "EWSR1",
              "Gene2": "WT1",
              "Type": "Fusion",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "positive",
              "summary": "EWSR1-WT1 Fusion positive  "
            }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "Phase 2 Cohort Expansion",
          "drug": "PBI-200",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {}
          ]
        }
      ],
      "docs": "<a href=\"https://trialplus.carisls.com/\" target=\"_blank\">Caris<\/a>",
      "locations": "Sioux Falls SD",
      "doclastupdate": "2023-01-20",
      "min_age": "18 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT04901806\" target=\"_blank\">NCT04901806<\/a>"
    }
  }
]
